Protagonist Therapeutics, Inc.
PTGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,339 | -$34,771 | -$11,655 | $131,674 |
| Dep. & Amort. | $361 | $304 | $239 | $536 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10,912 | $0 | $9,093 |
| Change in WC | $28,061 | -$3,879 | $124,692 | -$167,721 |
| Other Non-Cash | $8,980 | -$1,346 | $12,087 | -$2,760 |
| Operating Cash Flow | -$1,937 | -$28,780 | $125,363 | -$29,178 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$88 | -$813 | -$545 | -$310 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$161,117 | -$67,154 | -$214,040 | -$114,409 |
| Inv. Sales/Matur. | $102,650 | $122,782 | $120,183 | $105,994 |
| Other Inv. Act. | $0 | -$5 | $0 | $0 |
| Investing Cash Flow | -$58,555 | $54,810 | -$94,402 | -$8,725 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,659 | $2,925 | $11,922 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$479 | $4,031 |
| Financing Cash Flow | $5,659 | $2,925 | $11,443 | $4,031 |
| Forex Effect | $3 | $0 | $0 | $0 |
| Net Chg. in Cash | -$54,830 | $28,955 | $42,404 | -$33,872 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $168,543 | $139,878 | $97,249 | $131,346 |
| End Cash | $113,713 | $168,833 | $139,653 | $97,474 |
| Free Cash Flow | -$2,025 | -$29,593 | $124,818 | -$29,488 |